The DOI matches its Crossref record; 346 of the 346 references it cites were found in a registry or an index.
A guide to chemokines and their receptors
Open accessAbstract
The chemokines (or chemotactic cytokines) are a large family of small, secreted proteins that signal through cell surface G protein‐coupled heptahelical chemokine receptors. They are best known for their ability to stimulate the migration of cells, most notably white blood cells (leukocytes). Consequently, chemokines play a central role in the development and homeostasis of the immune system, and are involved in all protective or destructive immune and inflammatory responses. Classically viewed as inducers of directed chemotactic migration, it is now clear that chemokines can stimulate a variety of other types of directed and undirected migratory behavior, such as haptotaxis, chemokinesis, and haptokinesis, in addition to inducing cell arrest or adhesion. However, chemokine receptors on leukocytes can do more than just direct migration, and these molecules can also be expressed on, and regulate the biology of, many nonleukocytic cell types. Chemokines are profoundly affected by post‐translational modification, by interaction with the extracellular matrix (ECM), and by binding to heptahelical ‘atypical’ chemokine receptors that regulate chemokine localization and abundance. This guide gives a broad overview of the chemokine and chemokine receptor families; summarizes the complex physical interactions that occur in the chemokine network; and, using specific examples, discusses general principles of chemokine function, focusing particularly on their ability to direct leukocyte migration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–346 of 346
Spaan, A. N., Vrieling, M., Wallet, P., Badiou, C., Reyes-Robles, T., Ohneck, E. A., Benito, Y., de Haas, C. J. C., Day, C. J., Jennings, M. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6438 · Cited by 166
Bannert, N., Craig, S., Farzan, M., Sogah, D., Santo, N. V., Choe, H., & Sodroski, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1661 · Cited by 165
Salanga, C. L., & Handel, T. M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.004 · Cited by 165
Early postnatal lethality and cardiovascular defects in CXCR7‐deficient mice
Gerrits, H., Schenau, D. V. I., Bakker, N. E. C., van Disseldorp, A. J. M., Strik, A., Hermens, L. S., Koenen, T. B., Krajnc-Franken, M. A. M., & Gossen, J. A. (2008) · genesis · doi:10.1002/dvg.20387 · Cited by 164
High mobility group box 1 orchestrates tissue regeneration via CXCR4
Tirone, M., Tran, N. L., Ceriotti, C., Gorzanelli, A., Canepari, M., Bottinelli, R., Raucci, A., Maggio, S. D., Santiago, C. A., Mellado, M., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160217 · Cited by 164
Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists
Sohy, D., Yano, H., de Nadai, P., Urizar, E., Guillabert, A., Javitch, J. A., Parmentier, M., & Springael, J.-Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054809 · Cited by 163
Zheng, Y., Han, G. W., Abagyan, R., Wu, B., Stevens, R. C., Cherezov, V., Kufareva, I., & Handel, T. M. (2017) · Immunity · doi:10.1016/j.immuni.2017.05.002 · Cited by 163
Follicular regulatory T cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression
Vaeth, M., Müller, G., Stauss, D., Dietz, L., Klein-Hessling, S., Serfling, E., Lipp, M., Berberich, I., & Berberich-Siebelt, F. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20130604 · Cited by 160
Polysialylation controls dendritic cell trafficking by regulating chemokine recognition
Kiermaier, E., Moussion, C., Veldkamp, C. T., Gerardy-Schahn, R., de Vries, I., Williams, L. G., Chaffee, G. R., Phillips, A. J., Freiberger, F., Imre, R., et al. (2016) · Science · doi:10.1126/science.aad0512 · Cited by 160
Chen, C., Li, J., Bot, G., Szabó, I., Rogers, T. J., & Liu‐Chen, L. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.10.033 · Cited by 159
Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17
Maravillas‐Montero, J. L., Burkhardt, A. M., Hevezi, P. A., Carnevale, C. D., Smit, M. J., & Zlotnik, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401704 · Cited by 158
The chemokine receptor CCX‐CKR mediates effective scavenging of CCL19 in vitro
Comerford, I., Milasta, S., Morrow, V. A., Milligan, G., & Nibbs, R. J. B. (2006) · European Journal of Immunology · doi:10.1002/eji.200535716 · Cited by 155
Self-citationLee, J. S., Frevert, C. W., Wurfel, M. M., Peiper, S. C., Wong, V. A., Ballman, K. K., RUZINSKI, J. T., Rhim, J. S., Martin, T. R., & Goodman, R. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5244 · Cited by 153
Ehlert, J. E., Addison, C. A., Burdick, M. D., Kunkel, S. L., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6234 · Cited by 150
McDermott, D. H., Liu, Q., Velez, D. S., Lopez, L., Anaya‐O’Brien, S., Ulrick, J., Kwatemaa, N., Starling, J., Fleisher, T. A., Priel, D. A. L., et al. (2014) · Blood · doi:10.1182/blood-2013-09-527226 · Cited by 150
Zhivaki, D., Lemoine, S., Lim, A., Morva, A., Vidalain, P., Schandené, L., Casartelli, N., Rameix‐Welti, M., Hervé, P., Dériaud, E., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.010 · Cited by 150
Cardona, A. E., Sasse, M. E., Liu, L., Cardona, S. M., Mizutani, M., Savarin, C., Hu, T., & Ransohoff, R. M. (2008) · Blood · doi:10.1182/blood-2007-10-118497 · Cited by 149
The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors
Nibbs, R. J. B., Gilchrist, D. S., King, V., Ferra, A., Forrow, S., Hunter, K. D., & Graham, G. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30068 · Cited by 149
Self-citationInnate immunity and inflammation
Xiao, T. S. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.45 · Cited by 149
Choe, H., Moore, M. J., Owens, C. M., Wright, P. L., Vasilieva, N., Li, W., Singh, A. P., Shakri, R., Chitnis, C. E., & Farzan, M. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04478.x · Cited by 148
Nomiyama, H., Osada, N., & Yoshie, O. (2012) · Genes to Cells · doi:10.1111/gtc.12013 · Cited by 145
Cutaneous CXCL14 Targets Blood Precursors to Epidermal Niches for Langerhans Cell Differentiation
Schaerli, P., Willimann, K., Ebert, L. M., Walz, A., & Moser, B. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.012 · Cited by 145
Sarris, M., Masson, J., Maurin, D., van der Aa, L. M., Boudinot, P., Lortat‐Jacob, H., & Herbomel, P. (2012) · Current Biology · doi:10.1016/j.cub.2012.11.018 · Cited by 145
Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation
von Hundelshausen, P., Agten, S. M., Eckardt, V., Blanchet, X., Schmitt, M. M. N., Ippel, H., Neideck, C., Bidzhekov, K., Leberzammer, J., Wichapong, K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6650 · Cited by 145
Wilson, S., WILKINSON, G. F., & Milligan, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413475200 · Cited by 144
Pello, Ó. M., Martínez‐Muñoz, L., Parrillas, V., Serrano, A., Rodríguez-Frade, J. M., Toro, M. J., Lucas, P., Monterrubio, M., Martínez‐A, C., & Mellado, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200737630 · Cited by 143
The sweet spot: how GAGs help chemokines guide migrating cells
Monneau, Y. R., Arenzana‐Seisdedos, F., & Lortat‐Jacob, H. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0915-440r · Cited by 143
Collective Cell Motility Promotes Chemotactic Prowess and Resistance to Chemorepulsion
Malet‐Engra, G., Yu, W., Oldani, A., Rey-Barroso, J., Gov, N. S., Scita, G., & Dupré, L. (2015) · Current Biology · doi:10.1016/j.cub.2014.11.030 · Cited by 141
Gene copy number regulates the production of the human chemokine CCL3-L1
Townson, J. R., Barcellos, L. F., & Nibbs, R. J. B. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10<3016::aid-immu3016>3.0.co;2-d · Cited by 140
Self-citationLoos, T., Mortier, A., Gouwy, M., Ronsse, I., Put, W., Lenaerts, J., Damme, J. V., & Proost, P. (2008) · Blood · doi:10.1182/blood-2008-04-149039 · Cited by 138
CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11
Xanthou, G., Duchesnes, C., Williams, T. J., & Pease, J. E. (2003) · European Journal of Immunology · doi:10.1002/eji.200323787 · Cited by 138
Essential role of CCL21 in establishment of central self-tolerance in T cells
Kozai, M., Kubo, Y., Katakai, T., Kondo, H., Kiyonari, H., Schaeuble, K., Luther, S. A., Ishimaru, N., Ohigashi, I., & Takahama, Y. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161864 · Cited by 138
Interactions of Opioid and Chemokine Receptors: Oligomerization of , and with CCR5 on Immune Cells
Suzuki, S., Chuang, L. F., Yau, P. M., Doi, R. H., & Chuang, R. Y. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5638 · Cited by 136
Colvin, R. A., Campanella, G. S. V., Manice, L. A., & Luster, A. D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00556-06 · Cited by 136
Schnabel, R. B., Baumert, J., Barbalić, M., Dupuis, J., Ellinor, P. T., Durda, P., Dehghan, A., Bis, J. C., Illig, T., Morrison, A. C., et al. (2009) · Blood · doi:10.1182/blood-2009-05-221382 · Cited by 133
Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis
Duchêne, J., Novitzky‐Basso, I., Thiriot, A., Casanova-Acebes, M., Bianchini, M., Etheridge, S. L., Hub, E., Nitz, K., Artinger, K., Eller, K., et al. (2017) · Nature Immunology · doi:10.1038/ni.3763 · Cited by 131
New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model
Kleist, A. B., Getschman, A. E., Ziarek, J. J., Nevins, A. M., Gauthier, P., Chevigné, A., Szpakowska, M., & Volkman, B. F. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.04.007 · Cited by 129
Nibbs, R. J. B., Yang, J., Landau, N. R., Mao, J., & Graham, G. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17478 · Cited by 128
Self-citationThymocyte emigration is mediated by active movement away from stroma-derived factors
Poznansky, M. C., Olszak, I. T., Evans, R. H., Wang, Z., Foxall, R. B., Olson, D. P., Weibrecht, K. W., Luster, A. D., & Scadden, D. T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13853 · Cited by 123
Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo
Tharp, W. G., Yadav, R., Irimia, D., Upadhyaya, A., Samadani, A., Hurtado, O., Liu, S. Y., Munisamy, S., Brainard, D. M., Mahon, M. J., et al. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0905516 · Cited by 123
Generalized multi‐organ autoimmunity in CCR7‐deficient mice
Davalos‐Misslitz, A. C. M., Rieckenberg, J., Willenzon, S., Worbs, T., Kremmer, E., Bernhardt, G., & Förster, R. (2007) · European Journal of Immunology · doi:10.1002/eji.200636656 · Cited by 122
Biased Signaling at Chemokine Receptors
Corbisier, J., Galès, C., Huszagh, A., Parmentier, M., & Springael, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.596098 · Cited by 121
A role of the Duffy antigen for the maintenance of plasma chemokine concentrations
Fukuma, N., Akimitsu, N., Hamamoto, H., Kusuhara, H., Sugiyama, Y., & Sekimizu, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00293-6 · Cited by 121
Wong, L.-M., Myers, S. J., Tsou, C.-L., Gosling, J., Arai, H., & Charo, I. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1038 · Cited by 121
Chamberlain, G., Wright, K. T., Rot, A., Ashton, B. A., & Middleton, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002934 · Cited by 121
An Indispensable Role for the Chemokine Receptor CCR10 in IgA Antibody-Secreting Cell Accumulation
Morteau, O., Gerard, C. J., Lu, B., Ghiran, S., Rits, M., Fujiwara, Y., Law, Y., Distelhorst, K., Nielsen, E. M., Hill, E. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6309 · Cited by 117
The dependence of chemokine–glycosaminoglycan interactions on chemokine oligomerization
Dyer, D. P., Salanga, C. L., Volkman, B. F., Kawamura, T., & Handel, T. M. (2015) · Glycobiology · doi:10.1093/glycob/cwv100 · Cited by 117
Nibbs, R. J. B., Salcedo, T. W., Campbell, J. D., Yao, X.-T., Li, Y., Nardelli, B., Olsen, H. S., Morris, T. S., Proudfoot, A. E. I., Patel, V. P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1488 · Cited by 116
Self-citationDecoy Receptor CXCR7 Modulates Adrenomedullin-Mediated Cardiac and Lymphatic Vascular Development
Klein, K. R., Karpinich, N. O., Espenschied, S. T., Willcockson, H. H., Dunworth, W. P., Hoopes, S. L., Kushner, E. J., Bautch, V. L., & Caron, K. M. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.07.012 · Cited by 116
Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes
Ogilvie, P., Paoletti, S., Clark‐Lewis, I., & Uguccioni, M. (2003) · Blood · doi:10.1182/blood-2002-09-2773 · Cited by 115
Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands
Arenzana‐Seisdedos, F., & Parmentier, M. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.007 · Cited by 115
Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes
Spaan, A. N., Reyes-Robles, T., Badiou, C., Cochet, S., Boguslawski, K. M., Yoong, P., Day, C. J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.001 · Cited by 114
Red Blood Cell Invasion by Plasmodium vivax: Structural Basis for DBP Engagement of DARC
Batchelor, J. D., Malpede, B. M., Omattage, N. S., DeKoster, G. T., Henzler‐Wildman, K. A., & Tolia, N. H. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003869 · Cited by 114
Ignatov, A., Robert, J., Gregory, C. Y., & Schaller, H. C. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706909 · Cited by 114
CX3CR1 Tyrosine Sulfation Enhances Fractalkine-induced Cell Adhesion
Fong, A. M., Alam, S. M., Imai, T., Haribabu, B., & Patel, D. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201396200 · Cited by 112
Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease
Nishimura, M., Kuboi, Y., Muramoto, K., Kawano, T., & Imai, T. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04738.x · Cited by 111
Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network
Crosslin, D. R., McDavid, A., Weston, N., Nelson, S. C., Zheng, X., Hart, E., de Andrade, M., Kullo, I. J., McCarty, C. A., Doheny, K. F., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-1103-9 · Cited by 111
Hauser, M. A., Schaeuble, K., Kindinger, I., Impellizzieri, D., Krueger, W. A., Hauck, C. R., Boyman, O., & Legler, D. F. (2016) · Immunity · doi:10.1016/j.immuni.2015.12.010 · Cited by 111
Structural basis of ligand interaction with atypical chemokine receptor 3
Gustavsson, M., Wang, L., van Gils, N., Stephens, B. S., Zhang, P., Schall, T. J., Yang, S., Abagyan, R. A., Chance, M. R., Kufareva, I., et al. (2017) · Nature Communications · doi:10.1038/ncomms14135 · Cited by 111
Gupta, S. K., & Pillarisetti, K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2368 · Cited by 110
Chemokines and Chemokine Receptors in Multiple Sclerosis
Cheng, W., & Chen, G. (2014) · Mediators of Inflammation · doi:10.1155/2014/659206 · Cited by 108
Agrawal, L., Lu, X., Jin, Q., VanHorn-Ali, Z., Nicolescu, I., McDermott, D. H., Murphy, P. M., & Alkhatib, G. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2277-2287.2004 · Cited by 106
Dyer, D. P., Salanga, C. L., Johns, S. C., Valdambrini, E., Fuster, M. M., Milner, C. M., Day, A. J., & Handel, T. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.720953 · Cited by 106
Thuc, O. L., Blondeau, N., Nahon, J., & Rovère, C. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12855 · Cited by 105
Red Blood Cell Polymorphism and Susceptibility to Plasmodium vivax
Zimmerman, P. A., Ferreira, M. U., Howes, R. E., & Mercereau‐Puijalon, O. (2013) · Advances in Parasitology/Advances in parasitology · doi:10.1016/b978-0-12-407826-0.00002-3 · Cited by 105
Comodulation of CXCR4 and CD26 in Human Lymphocytes
Herrera, C., Morimoto, C., Blanco, J., Mallol, J., Arenzana‐Seisdedos, F., Lluís, C., & Franco, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004586200 · Cited by 104
Dimberg, A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_21 · Cited by 102
Liu, Q., Chen, H., Ojode, T., Gao, X., Anaya‐O’Brien, S., Turner, N., Ulrick, J., DeCastro, R. M., Kelly, C., Cardones, A. R., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395608 · Cited by 102
What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?
Kufareva, I., Gustavsson, M., Zheng, Y., Stephens, B. S., & Handel, T. M. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022942 · Cited by 102
Beyond Chemoattraction: Multifunctionality of Chemokine Receptors in Leukocytes
López-Cotarelo, P., Gómez-Moreira, C., Criado‐García, O., Sánchez, L., & Rodríguez‐Fernández, J. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.08.004 · Cited by 101
Antimicrobial Activities of Chemokines: Not Just a Side-Effect?
Wolf, M., & Moser, B. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00213 · Cited by 99
Ziarek, J. J., Kleist, A. B., London, N., Raveh, B., Montpas, N., Bonneterre, J., St‐Onge, G., DiCosmo-Ponticello, C. J., Koplinski, C. A., Roy, I., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aah5756 · Cited by 99
Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5
Petkovic, V., Moghini, C., Paoletti, S., Uguccioni, M., & Gerber, B. O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309283200 · Cited by 97
Hu, Z., Lancaster, J. N., Sasiponganan, C., & Ehrlich, L. I. R. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150178 · Cited by 93
Regulation of Chemokine Activity – A Focus on the Role of Dipeptidyl Peptidase IV/CD26
Metzemaekers, M., Damme, J. V., Mortier, A., & Proost, P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00483 · Cited by 93
The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling
Yu, S., Crawford, D., Tsuchihashi, T., Behrens, T. W., & Srivastava, D. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22549 · Cited by 92
D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion
Lee, K. M., McKimmie, C. S., Gilchrist, D. S., Pallas, K. J., Nibbs, R. J. B., Garside, P., McDonald, V., Jenkins, C. R., Ransohoff, R. M., Liu, L., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344044 · Cited by 89
Self-citationZhu, B., Xu, D., Deng, X., Chen, Q., Huang, Y., Peng, H., Li, Y., Jia, B., Thoreson, W. B., Ding, W., et al. (2012) · Stem Cells · doi:10.1002/stem.1239 · Cited by 89
Chakera, A., Seeber, R. M., John, A. E., Eidne, K. A., & Greaves, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.040915 · Cited by 88
Bias in chemokine receptor signalling
Zweemer, A. J. M., Toraskar, J., Heitman, L. H., & IJzerman, A. P. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.02.004 · Cited by 87
Tan, J., Ludeman, J. P., Wedderburn, J., Canals, M., Hall, P., Butler, S. J., Taleski, D., Christopoulos, A., Hickey, M. J., Payne, R. J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447359 · Cited by 87
Vaahtomeri, K., Brown, M., Hauschild, R., De Vries, I., Leithner, A. F., Mehling, M., Kaufmann, W. A., & Sixt, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.027 · Cited by 86
Comerford, I., Nibbs, R. J. B., Litchfield, W., Bunting, M. D., Harata‐Lee, Y., Haylock‐Jacobs, S., Forrow, S., Körner, H., & McColl, S. R. (2010) · Blood · doi:10.1182/blood-2010-01-264390 · Cited by 85
Self-citationEpidermis instructs skin homing receptor expression in human T cells
McCully, M. L., Ladell, K., Hakobyan, S., Mansel, R. E., Price, D. A., & Moser, B. (2012) · Blood · doi:10.1182/blood-2012-05-433037 · Cited by 84
Kulkarni, N., Pathak, M., & Lal, G. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ru0716-327r · Cited by 84
Hansell, C. A. H., Schiering, C., Kinstrie, R., Ford, L. B., Bordon, Y., McInnes, I. B., Goodyear, C. S., & Nibbs, R. J. B. (2011) · Blood · doi:10.1182/blood-2010-11-317115 · Cited by 83
Self-citationStructural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3
Liang, W. G., Triandafillou, C. G., Huang, T., Zulueta, M. M. L., Banerjee, S., Dinner, A. R., Hung, S., & Tang, W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523981113 · Cited by 83
Chemokine receptors in allergic diseases
Castan, L., Magnan, A., & Bouchaud, G. (2017) · Allergy · doi:10.1111/all.13089 · Cited by 80
Cowan, J. E., McCarthy, N. I., Parnell, S. M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400993 · Cited by 76
Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
Collins, P. J., McCully, M. L., Martínez‐Muñoz, L., Santiago, C. A., Wheeldon, J., Caucheteux, S. M., Thelen, S., Cecchinato, V., Laufer, J. M., Purvanov, V., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700013r · Cited by 76
Parenty, G., Appelbe, S., & Milligan, G. (2008) · Biochemical Journal · doi:10.1042/bj20071689 · Cited by 75
Millard, C. J., Ludeman, J. P., Canals, M., Bridgford, J. L., Hinds, M. G., Clayton, D. J., Christopoulos, A., Payne, R. J., & Stone, M. J. (2014) · Structure · doi:10.1016/j.str.2014.08.023 · Cited by 75
The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density
Lee, K. M., Danuser, R., Stein, J. V., Graham, D., Nibbs, R. J. B., & Graham, G. J. (2014) · The EMBO Journal · doi:10.15252/embj.201488887 · Cited by 74
Self-citationChemokine isoforms and processing in inflammation and immunity
Proost, P., Struyf, S., Damme, J. V., Fiten, P., Ugarte-Berzal, E., & Opdenakker, G. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.009 · Cited by 73
Starr, A. E., Dufour, A., Maier, J., & Overall, C. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.314609 · Cited by 72
Tripathi, A., Vana, P. G., Chavan, T., Brueggemann, L. I., Byron, K. L., Tarasova, N. I., Volkman, B. F., Gaponenko, V., & Majetschak, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417564112 · Cited by 72
Bryce, S. A., Wilson, R. A. M., Tiplady, E. M., Asquith, D. L., Bromley, S. K., Luster, A. D., Graham, G. J., & Nibbs, R. J. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501542 · Cited by 71
Self-citationThanabalasuriar, A., Neupane, A. S., Wang, J., Krummel, M. F., & Kubes, P. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.052 · Cited by 70
Chemoattractant Receptor Signaling and the Control of Lymphocyte Migration
Kehrl, J. H. (2006) · Immunologic Research · doi:10.1385/ir:34:3:211 · Cited by 69
Critical roles of chemokine receptor CCR10 in regulating memory IgA responses in intestines
Hu, S., Yang, K., Yang, J., Li, M., & Xiong, N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100156108 · Cited by 69
Chemokine‐guided cell migration and motility in zebrafish development
Bussmann, J., & Raz, E. (2015) · The EMBO Journal · doi:10.15252/embj.201490105 · Cited by 69
β2-Adrenergic Receptor Signaling in the Cardiac Myocyte is Modulated by Interactions With CXCR4
LaRocca, T. J., Schwarzkopf, M., Altman, P. R., Zhang, S., Gupta, A., Gomes, I., Alvin, Z. V., Champion, H. C., Haddad, G. E., Hajjar, R. J., et al. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181f713fe · Cited by 67
Identification and profiling of CXCR3 – CXCR4 chemokine receptor heteromer complexes
Watts, A., van Lipzig, M., Jaeger, W., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12064 · Cited by 66
Ghosh, M. C., Makena, P. S., Gorantla, V. K., Sinclair, S. E., & Waters, C. M. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00321.2011 · Cited by 65
Modulation of chemokine activity by viruses
Alcamı́, A., & Lira, S. A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.004 · Cited by 65
Chemokine-Mediated Choreography of Thymocyte Development and Selection
Lancaster, J. N., Li, Y., & Ehrlich, L. I. R. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.10.007 · Cited by 65
CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120 IIIB binding to the cell surface
Martínez‐Muñoz, L., Barroso, R., Dyrhaug, S. Y., Navarro, G., Lucas, P., Soriano, S. F., Vega, B., Costas, C., Muñoz‐Fernández, M. Á., Santiago, C. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322887111 · Cited by 64
Yu, C., Peden, K., Zaitseva, M. B., Golding, H., & Farber, J. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1293 · Cited by 61
I-TAC/CXCL11 is a natural antagonist for CCR5
Petkovic, V., Moghini, C., Paoletti, S., Uguccioni, M., & Gerber, B. O. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103570 · Cited by 59
Kulkarni, H. R., Marconi, V. C., He, W., Landrum, M. L., Okulicz, J. F., Delmar, J., Kazandjian, D. G., Castiblanco, J., Ahuja, S. S., Wright, E., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215186 · Cited by 59
Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement
Smith, N., Pietrancosta, N., Davidson, S., Dutrieux, J., Chauveau, L., Cutolo, P., Dy, M., Scott‐Algara, D., Manoury, B., Zirafi, O., et al. (2017) · Nature Communications · doi:10.1038/ncomms14253 · Cited by 58
Fy phenotype and gender determine plasma levels of monocyte chemotactic protein
Jilma‐Stohlawetz, P., Homoncik, M., Drucker, C., Marsik, C. L., Rot, A., Mayr, W. R., Seibold, B. T., & Jilma, B. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41030378.x · Cited by 57
Ticks from diverse genera encode chemokine-inhibitory evasin proteins
Hayward, J. A., Sanchez, J., Perry, A., Huang, C., Rodriguez-Valle, M., Canals, M., Payne, R. J., & Stone, M. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.807255 · Cited by 57
Haege, S., Einer, C., Thiele, S., Mueller, W., Nietzsche, S., Lupp, A., Mackay, F., Schulz, S., & Stumm, R. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042814 · Cited by 55
van der Vorst, E. P. C., Döring, Y., & Weber, C. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306359 · Cited by 55
Functional Analysis of the Chemokine Receptor CCR3 on Airway Epithelial Cells
Beck, L. A., Tancowny, B. P., Brummet, M. E., Asaki, S. Y., Curry, S. L., Penno, M. B., Foster, M. L., Bahl, A. K., & Stellato, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3344 · Cited by 54
Madigan, J., Freeman, D. J., Menzies, F. M., Forrow, S., Nelson, S. M., Young, A., Sharkey, A., Moffett, A., Graham, G. J., Greer, I. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902118 · Cited by 54
Self-citationHu, Z., Li, Y., van Nieuwenhuijze, A. E. M., Selden, H. J., Jarrett, A. M., Sorace, A. G., Yankeelov, T. E., Liston, A., & Ehrlich, L. I. R. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.016 · Cited by 51
Walley, N. M., Jülg, B. D., Dickson, S. P., Fellay, J., Ge, D., Walker, B. D., Carrington, M. N., Cohen, M. S., de Bakker, P. I. W., Goldstein, D. B., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.011 · Cited by 46
EBI2 regulates CXCL13‐mediated responses by heterodimerization with CXCR5
Barroso, R., Martínez‐Muñoz, L., Barrondo, S., Vega, B., Holgado, B., Lucas, P., Baı́llo, A., Sallés, J., Rodrı́guez-Frade, J. M., & Mellado, M. (2012) · The FASEB Journal · doi:10.1096/fj.12-208876 · Cited by 45
CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity
Bunting, M. D., Comerford, I., Seach, N., Hammett, M. V., Asquith, D. L., Körner, H., Boyd, R. L., Nibbs, R. J. B., & McColl, S. R. (2012) · Blood · doi:10.1182/blood-2012-06-434886 · Cited by 44
Self-citationJanssens, R., Mortier, A., Boff, D., Vanheule, V., Gouwy, M., Franck, C., Larsen, O., ROSENKILDE, M. M., Damme, J. V., Amaral, F. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11516 · Cited by 43
CXCR4 and CXCR7 cooperate during tangential migration of facial motoneurons
Cubedo, N., Cerdan, E., Sapède, D., & Rossel, M. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.01.003 · Cited by 42
Role of chemokines polymorphisms in diseases
Guergnon, J., & Combadière, C. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.04.010 · Cited by 42
Jülg, B. D., Reddy, S., van der Stok, M., Kulkarni, S., Qi, Y., Bass, S. E., Gold, B., Nalls, M. A., Nelson, G. W., Walker, B. D., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.009 · Cited by 41
Analysis of Post-translational CCR8 Modifications and Their Influence on Receptor Activity
Gutiérrez, J., Kremer, L., Zaballos, Á., Goya, Í., Martínez‐A, C., & Márquez, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309689200 · Cited by 41
Winkler, C. A., An, P., Johnson, R. C., Nelson, G. W., & Kirk, G. D. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.010 · Cited by 40
Connell, B. J., Sadir, R., Baleux, F., Laguri, C., Kleman, J.-P., Luo, L., Arenzana‐Seisdedos, F., & Lortat‐Jacob, H. (2016) · Science Signaling · doi:10.1126/scisignal.aaf1839 · Cited by 40
A Chemoattractant-Guided Walk Through Lymphopoiesis
Lim, V., Zehentmeier, S., Fistonich, C., & Pereira, J. P. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.02.001 · Cited by 40
Pei, X., Sun, Q., Zhang, Y., Wang, P., Peng, X., Guo, C., Xu, E., Zheng, Y., Mo, X., Ma, J., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300758 · Cited by 39
CCL2 nitration is a negative regulator of chemokine-mediated inflammation
Barker, C. E., Thompson, S., O’Boyle, G., Lortat‐Jacob, H., Sheerin, N., Ali, S., & Kirby, J. A. (2017) · Scientific Reports · doi:10.1038/srep44384 · Cited by 39
Mogamulizumab for the treatment of T-cell lymphoma
Makita, S., & Tobinai, K. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1347634 · Cited by 39
Adage, T., Piccinini, A. M., Falsone, A., Trinker, M. U., Robinson, J. I., Gesslbauer, B., & Kungl, A. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02089.x · Cited by 38
Evasins: Therapeutic Potential of a New Family of Chemokine-Binding Proteins from Ticks
Bonvin, P., Power, C., & Proudfoot, A. E. I. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00208 · Cited by 38
Targeting cell migration in rheumatoid arthritis
Asquith, D. L., Bryce, S. A., & Nibbs, R. J. B. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000150 · Cited by 37
Self-citationKremer, K. N., Clift, I. C., Miamen, A. G., Bamidele, A. O., Qian, N. X., Humphreys, T. D., & Hedin, K. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100820 · Cited by 37
Duffy Antigen Polymorphisms Do Not Alter Progression of HIV in African Americans in the MACS Cohort
Horne, K., Li, X., Jacobson, L. P., Palella, F. J., Jamieson, B. D., Margolick, J. B., Martinson, J. J., Turkozu, V., Visvanathan, K., & Woolley, I. J. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.013 · Cited by 35
Lucas, B., White, A. J., Ulvmar, M. H., Nibbs, R. J. B., Sitnik, K., Agace, W. W., Jenkinson, W. E., Anderson, G., & Rot, A. (2014) · European Journal of Immunology · doi:10.1002/eji.201445015 · Cited by 33
Self-citationHayasaka, H., Kobayashi, D., Yoshimura, H., Nakayama, E. E., Shioda, T., & Miyasaka, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117454 · Cited by 31
Atypical chemokine receptor 4 shapes activated B cell fate
Kara, E. E., Bastow, C. R., McKenzie, D. R., Whyte, C. E., Fenix, K. A., Babb, R., Norton, T. S., Zotos, D., Rodda, L. B., Hermes, J. R., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171067 · Cited by 31
Self-citationTeoh, P. J., Menzies, F. M., Hansell, C. A. H., Clarke, M., Waddell, C., Burton, G. J., Nelson, S. M., & Nibbs, R. J. B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401096 · Cited by 26
Self-citationAtypical chemokine receptor ACKR2 controls branching morphogenesis in the developing mammary gland
Wilson, G. J., Hewit, K. D., Pallas, K. J., Cairney, C. J., Lee, K. M., Hansell, C. A. H., Stein, T., & Graham, G. J. (2016) · Development · doi:10.1242/dev.139733 · Cited by 26
Chemokine receptors in psoriasis
Singh, T. P., Lee, C. H., & Farber, J. M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.838220 · Cited by 23
Hewit, K. D., Fraser, A. R., Nibbs, R. J. B., & Graham, G. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534545 · Cited by 17
Self-citationMoreno‐Fernandez, M. E., Aliberti, J., Groeneweg, S., Köhl, J., & Chougnet, C. A. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0099 · Cited by 15
Chemokine CXCL8 modulates GluR1 phosphorylation
Catalano, M., Trettel, F., Cipriani, R., Lauro, C., Sobrero, F., Eusebi, F., & Limatola, C. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.017 · Cited by 10
Cited by
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Neutrophil chemoattractant receptors in health and disease: Double-edged swords
Metzemaekers, M., Gouwy, M., & Proost, P. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0412-0 · Cited by 570
Cambier, S., Gouwy, M., & Proost, P. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00974-6 · Cited by 591
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19
Meckiff, B. J., Ramírez-Suástegui, C., Fajardo, V., Chee, S. J., Kusnadi, A., Simon, H., Eschweiler, S., Grifoni, A., Pelosi, E., Weiskopf, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.001 · Cited by 561
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Metadata
- Authors
- Hughes, C. E., & Nibbs, R. J. B.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2018-04-24
- Volume
- 285
- Issue
- 16
- Pages
- 2944-2971
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2797069917
- Cited by
- 1,412
- References
- 346
- FWCI
- 25.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.